目的 探讨腹腔镜肝切除术治疗原发性肝癌的临床疗效。方法 选取2019年10月—2020年11月收治的68例原发性肝癌患者,按不同手术方式分为对照组（n=28）和观察组（n=40）。对照组实施开腹肝切除术,观察组实施腹腔镜肝切除术,比较两组围术期手术指标、肝功能水平、术后恢复及并发症。结果 观察组手术时间短于对照组,术中出血量少于对照组,术后ICU时间、住院时间、胃肠功能恢复时间均短于对照组（P<0.05）;术后天冬氨酸氨基转移酶（AST）、丙氨酸氨基转移酶（ALT）、总胆红素（TBIL）等肝功能指标亦优于对照组（P<0.05）;胸腔积液、腹水、胆漏、切口感染、肝衰等并发症发生率低于对照组（P<0.05）。结论 腹腔镜肝切除术治疗原发性肝癌有效安全。

Objective To investigate the clinical efficacy of laparoscopic hepatectomy on primary liver cancer. Methods A total of 68 patients with primary liver cancer from October 2019 to November 2020 were divided into a control group （n=28） and an observation group （n=40） according to different surgical methods. The control group received open hepatectomy and the observation group underwent laparoscopic hepatectomy. Perioperative indexes, liver function, postoperative recovery, and complications were compared between the two groups. Results The observation group showed shorter operation time, less amount of intraoperative bleeding, shorter postoperative ICU time, hospital stay, and gastrointestinal function recovery time than the control group （P<0.05）. The indexes of liver function such as aspartate aminotransferase （AST）, alanine aminotransferase （ALT）, and total bilirubin （TBIL） in the observation group were better than those in the control group （P<0.05）. The incidence rates of complications such as pleural effusion, ascites, bile leakage, incision infection, and liver failure in the observation group were lower than those in the control group （P<0.05）. Conclusion Laparoscopic hepatectomy has an ideal and safe effect on primary liver cancer.